Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2025-12-24 @ 11:04 PM
NCT ID:
NCT00331669
Eligibility Criteria:
Inclusion Criteria:
* Operational criteria for tardive dystonia for \> 18 months after cessation of neuroleptic exposure
* 18-75 years
* Relevant functional impairment in daily living activities
* BFMDRS \> 8 or AIMS \> 16
* Informed written consent
Exclusion Criteria:
* PANNS \>60 (Schizophrenia)
* Hamilton-Score \> 18 (Depression)
* MATTIS-Score \<120 (Dementia)
* Preceding stereotactic neurosurgery
* Pronounced brain atrophy
* Increased bleeding risk
* Decreased immune status
* Botulinum Toxin treatment within the last 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00331669
Study Brief:
Protocol Section:
NCT00331669